Last reviewed · How we verify
NCT07192861
BETA - Pilot Study
trial in Diabetes (DM) in 28 participants. Enrolling by invitation.
30 November 2025
Quick facts
| Lead sponsor | 4YouandMe |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 28 |
| Start date | 1 July 2025 |
| Primary completion | 30 November 2025 |
| Estimated completion | 30 November 2025 |
| Sites | 1 location across United States |
Conditions studied
- Diabetes (DM) — all drugs for Diabetes (DM) →
Sponsor
4YouandMe
Who can join
18 and older, any sex, with Diabetes (DM). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is testing the feasibility of using non-invasive, remote digital tools including continuous glucose monitors (CGMs) and Oura ring and the Empatica EmbracePlus smart wristband to predict the function of beta-cells, the cells in the pancreas that secrete insulin. This study is being initially done with individuals with Type 1 diabetes, so that in the future these methods can be tested in a larger study of individuals with Type 2 diabetes or prediabetics. The eventual aim of this work is to develop remote digital tools that can predict the health and functioning of the pancreas in people with prediabetes and Type 2 diabetes, allowing personalized treatment approaches to preserve insulin secretion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07192861
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes (DM)
Currently open trials in the same condition.
- NCT07530575 — Limosilactobacillus Fermentum CRL 1446 - CONICET CASASCO · NA · active not recruiting
- NCT07167693 — Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes · Phase 1, PHASE2 · recruiting
- NCT07205978 — Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis · active not recruiting
- NCT07252700 — Preventing Diabetes: Impact of an EMR-Based Intervention for Enhanced Pre-Diabetes Management in Primary Care · NA · recruiting
- NCT07285330 — Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes · recruiting
Other 4YouandMe trials
Trials by the same sponsor.
- NCT06907953 — CZI Rare As One: Co-designing an App and Wearable Based Compass for Rare Diseases · completed
- NCT05753605 — My Experiences: Leveraging Digital Technologies to Better Understand Mental Health · completed
- NCT04714905 — Better Understanding the Metamorphosis of Pregnancy (BUMP) · completed
- NCT04713111 — Stress and Recovery in Frontline COVID-19 Workers · NA · completed
- NCT04809194 — Stress in Crohn's Disease · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07192861 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by 4YouandMe
- Last refreshed: 25 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07192861.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing